Thrombosis and Disseminated Intravascular Coagulation following Treatment with the Prothrombin Complex Concentrate, DEFIX

Please copy the URL and add it into your RSS Feed Reader.

Facebook Linkedin Weibo

Thromb Haemost 1999; 81(04): 667
DOI: 10.1055/s-0037-1614549

Letters to the Editor

Schattauer GmbH

P. H. Roddie

¹From the Dept. of Haematology, Royal Infirmary of Edinburgh, Edinburgh, UK

,

C. Stirling

¹From the Dept. of Haematology, Royal Infirmary of Edinburgh, Edinburgh, UK

,

E. E. Mayne

¹From the Dept. of Haematology, Royal Infirmary of Edinburgh, Edinburgh, UK

,

C. A. Ludlam

¹From the Dept. of Haematology, Royal Infirmary of Edinburgh, Edinburgh, UK

Further Information

Publication History

Received 06 November 1998

Accepted 10 December 1998

Publication Date:
09 December 2017 (online)

References
1 BCSH guidelines on oral anticoagulation: third edition. Br J Haematol. 1998; 101: 374-87.

MissingFormLabel
PubMed Search in Google Scholar
2 Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR. Preston EF.Emergency oral anticoagulant reversal: the relative efficacy of infusions offresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997; 77: 477-80.

MissingFormLabel
Thieme Connect PubMed Search in Google Scholar
3 Lusher JM. Prediction and management of adverse events associated withthe use of factor IX complex concentrates. Semin Hematol 1993; 30: 36-40.

MissingFormLabel
PubMed Search in Google Scholar
4 Prowse CV, Cash JD. The use of factor IX concentrates in man: a 9-year experience of Scottish concentrates in the South-East of Scotland. Br J Haematol 1981; 47: 91-104.

MissingFormLabel
Crossref PubMed Search in Google Scholar
5 McNeill SA, Ewing JC, Wallace WA, Stewart LH. Venous infarction of atesticle following factor IX concentrate (DEFIX) [letter]. Br J Haematol 1998; 101-210.

MissingFormLabel
PubMed Search in Google Scholar